Targeted disruption of the f2-microglobulin (p2m) gene results in major histocompatibility complex (MHC) class I deficiency and virtual disappearance offunctional CD8+ cytotoxic T lymphocytes (CTLs) in 13m-deficient (132m -/-) mice. We asked whether the 32m -/-mice are able to reject Intraperitoneal (i.p.) injection of allogeneic major histocompatibility complex (MHC) class I-bearing tumor cells is followed by destruction of injected cells and survival of mice and is routinely used to obtain peritoneal exudate leukocytes (PELs) containing a,B T-cell receptor-positive (TCR+) cytotoxic T lymphocytes (CTLs) with high, MHC class I-specific lytic activity toward injected tumor cells (1-3).Cell-surface expression of MHC class I requires 12-microglobulin (32m) since no MHC class I antigens were detected on cell mutants lacking expression of 132m (4), and it is believed that 3m is needed for stabilization of peptide-H-2 complex, its correct folding, and cell membrane expression (5,6). Expression of MHC class I is considered instrumental in thymic education of MHC class I-restricted CD8+ CTLs and many studies have supported this view (7,8). It was reported that gene-targeted disruption of 2m results in the virtual disappearance of surface-expressed native MHC class I antigens and that 2m-deficient (/2m -/-) animals lack functional CD8+ CTLs (9-12). A very low percentage of or no CD8+CD4-cells were found in the thymus or periphery of (2m -/-mice with no significant effect on the development or survival of such animals, raising doubts about the functional significance of CD8+ CTLs. We confirmed in this study the original reports that naive 32m-deficient mice, in contrast to normal mice, have dramatically decreased levels of MHC class I antigen (Fig. lA a and b) and no more than 0.5% of CD8+a/3TCR+ cells were found in the thymus or peripheral organs, such as lymph nodes (Fig. lA c and d) and spleen (data not shown). We were trying to address the issue of the role of CD8+ CTLs by using an in vivo model, in which highly lytic and antigen-specific CD8+ PEL CTLs are implicated in tumor cell rejection (1-3) and could be easily recovered from peritoneal cavities of i.p. tumor-injected mice.
MATERIALS AND METHODSMice. C57BL/6, 129/J (129J x C57BL/6)F1, DBA/2, and 12m -/-mice were 6-8 weeks old at the beginning of the experiments and were maintained in a pathogen-free environment. 32m -/ -mice used in the study were derived from embryonic stem cells (129/ola) in which the P2m gene was disrupted by gene targeting. Chimeras obtained from these cells were mated with C57BL/6 and offspring carrying the defective gene were crossed to obtain animals homozygous for the mutation (10).Cells. Thymocytes and lymph node cells were obtained as a single cell suspension after lymphoid organs were taken from control or immunized mice. The routine protocol was used to obtain a PEL suspension (1, 2). Briefly, (32m +/+ and/or 82m -/ -mice were i.p. injected with 6-25 x 106 P815 CTLs during immunization of P2m -/-mice) or with tumor cells gr...